Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$0.21 - $0.35 $4,311 - $7,185
20,529 Added 123.22%
37,190 $9,000
Q3 2022

Nov 10, 2022

SELL
$0.41 - $8.8 $2,422 - $51,990
-5,908 Reduced 26.18%
16,661 $6,000
Q2 2022

Aug 15, 2022

SELL
$0.42 - $0.65 $6,842 - $10,589
-16,291 Reduced 41.92%
22,569 $14,000
Q1 2022

May 12, 2022

SELL
$0.54 - $2.74 $3,736 - $18,960
-6,920 Reduced 15.12%
38,860 $24,000
Q4 2021

Feb 14, 2022

BUY
$2.33 - $3.37 $95,164 - $137,640
40,843 Added 827.28%
45,780 $123,000
Q3 2021

Nov 15, 2021

SELL
$2.52 - $2.99 $22,140 - $26,270
-8,786 Reduced 64.02%
4,937 $13,000
Q2 2021

Aug 16, 2021

BUY
$2.6 - $3.65 $9,544 - $13,399
3,671 Added 36.52%
13,723 $39,000
Q1 2021

May 17, 2021

SELL
$2.73 - $4.5 $43,832 - $72,252
-16,056 Reduced 61.5%
10,052 $34,000
Q4 2020

Feb 16, 2021

SELL
$2.6 - $3.32 $236,875 - $302,471
-91,106 Reduced 77.73%
26,108 $69,000
Q3 2020

Nov 16, 2020

BUY
$2.46 - $4.27 $233,837 - $405,889
95,056 Added 428.99%
117,214 $366,000
Q2 2020

Aug 13, 2020

BUY
$1.45 - $4.3 $32,129 - $95,279
22,158 New
22,158 $92,000
Q4 2019

Feb 07, 2020

SELL
$1.65 - $2.48 $22,006 - $33,075
-13,337 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$1.48 - $2.52 $138,862 - $236,441
-93,826 Reduced 87.55%
13,337 $22,000
Q2 2019

Aug 13, 2019

BUY
$2.45 - $3.32 $248,699 - $337,013
101,510 Added 1795.68%
107,163 $268,000
Q1 2019

May 14, 2019

BUY
$2.52 - $3.24 $14,245 - $18,315
5,653 New
5,653 $17,000
Q4 2018

Feb 14, 2019

SELL
$1.92 - $4.1 $614 - $1,312
-320 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$3.39 - $4.61 $8,864 - $12,055
-2,615 Reduced 89.1%
320 $1,000
Q2 2018

Aug 15, 2018

BUY
$1.89 - $4.95 $3,538 - $9,266
1,872 Added 176.11%
2,935 $12,000
Q1 2018

May 15, 2018

SELL
$2.06 - $2.38 $13,194 - $15,243
-6,405 Reduced 85.77%
1,063 $2,000
Q4 2017

Feb 09, 2018

BUY
$1.91 - $2.83 $14,263 - $21,134
7,468
7,468 $16,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $385M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.